The transatlantic healthcare landscape presents a complex tapestry of diverse strategies to cancer care. While both the United States and Europe boast remarkable advancements in oncology, significant discrepancies exist in their respective architectures. This article delves into these distinctions, exploring the factors influencing them and highlig